Jazz Pharmaceuticals News

UBS Adjusts Price Target on Jazz Pharmaceuticals to $117 From $121, Maintains Neutral Rating

MT NewswiresMay 3 11:49 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaMay 3 10:28 ET

Analysts Offer Insights on Healthcare Companies: Kronos Bio (KRON), Jazz Pharmaceuticals (JAZZ) and KalVista Pharmaceuticals (KALV)

TipRanksMay 3 06:32 ET

RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TipRanksMay 2 06:35 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaMay 2 06:33 ET

Buy Rating Affirmed: Jazz Pharmaceuticals' Resilient Base and Promising Pipeline Drive Positive Outlook

TipRanksMay 2 06:09 ET

Barclays Remains a Buy on Jazz Pharmaceuticals (JAZZ)

TipRanksMay 1 03:55 ET

Jazz Pharmaceuticals (JAZZ) Gets a Buy From Barclays

TipRanksApr 23 05:59 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaApr 10 09:36 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Jazz Pharmaceuticals (JAZZ)

TipRanksApr 8 22:00 ET

JPMorgan Raises Jazz Pharmaceuticals' Price Target to $190 From $170, Maintains Overweight Rating

MT NewswiresMar 25 14:14 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaMar 22 13:48 ET

Optimistic Outlook on Jazz Pharmaceuticals' Zanidatamab Across Multiple Cancer Types: A Buy Rating Analysis

TipRanksMar 21 02:20 ET

Buy Rating Affirmed for Jazz Pharmaceuticals on Strong Zanidatamab Revenue Prospects and Clinical Milestones

TipRanksMar 20 06:45 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaMar 20 06:37 ET

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Shockwave Medical (SWAV) and Healthequity (HQY)

TipRanksMar 20 05:10 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaMar 15 09:36 ET

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Align Tech (ALGN) and Jazz Pharmaceuticals (JAZZ)

TipRanksMar 15 08:20 ET

Jazz Pharmaceuticals Analyst Ratings

BenzingaMar 14 07:23 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Jazz Pharmaceuticals (JAZZ) and ScPharmaceuticals (SCPH)

TipRanksMar 14 06:20 ET